NCT02607332View on ClinicalTrials.gov

Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

Paclitaxel

Trial Locations (1)

138-736

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT02607332 - Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib | Biotech Hunter | Biotech Hunter